Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-07-19
2005-07-19
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S101000
Reexamination Certificate
active
06919334
ABSTRACT:
Compounds of the formula:are useful for the treatment of depression (including but not limited to major depressive disorder, childhood depression and dysthymia), anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder (also known as pre-menstrual syndrome), attention deficit disorder (with and without hyperactivity), obsessive compulsive disorder, social anxiety disorder, generalized anxiety disorder, obesity, eating disorders such as anorexia nervosa and bulimia nervosa, vasomotor flushing, cocaine and alcohol addiction, sexual dysfunction and related illnesses.
REFERENCES:
patent: WO 94/01437 (1994-01-01), None
Bundgaard, H. (ed.),Design of Prodrugs, Elsevier (1985), Ch. 1 (pp. 1-92), Ch. 4 (pp. 157-176), Ch. 5 (pp. 177-198), and Ch. 6 (pp. 199-241).
Bundgaard, H. et al., “Glycolamide Esters as Biolabile Prodrugs of Carboxylic Acid Agents: Synthesis, Stability, Bioconversion, and Physicochemical Properties,”J. of Pharmaceutical Sciences, 77(4):285-298 (1988).
Eliel, E. L.,Stereochemistry of Carbon Compounds, McGraw Hill, NY (1962) Ch. 4, pp. 46-87.
Higuchi and Stella (eds.),Prodrugs as Novel Drug Delivery Systems, American Chemical Society (1975), pp. 1-115 and 196-223.
Jacques, J. et al.,Enantiomers, Racemates and Resolutions, Wiley Interscience, NY (1981) pp. 251-434.
Remington's Pharmaceutical Sciences, 17thEd., Gennaro, A. R. (Ed.), Mack Publishing Company, Easton, PA (1985) pp. 1409-1677.
Widder, et al. (ed.),Methods in Enzymology, vol. 112, Academic Press (1985), pp. 309-396.
Artigas, F., et al., “Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors,”Arch Gen Psychiatry, Mar. 1994, 51, 248-251.
Blier, P., et al., “Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression,”J. of Clinical Psychopharmacology, 1995, 15(3), 217-222.
Bundgaard, H., “Means to enhance penetration; Prodrugs as a means to improve the delivery of peptide drugs,”Advanced Drug Deliver Reviews, 1992, 8, 1-38.
Cheetham, S.C., et al., “[3H]paroxetine binding in a rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments,”Neuropharmacol., 1993, 32(8), 737-743.
Hall, M.D., et al., “{3H}8-hydroxy-2-(Di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain,”J. Neurochem., 1985, 44, 1685-1696.
Krogsgaard-Larsen, et al. (Eds.), “Design and Application of Prodrugs,”Texbook of Drug design and Development, 1991, Chap. 5, 113-191.
Lazareno, S., “Pharmacological characterization of acetylcholine-stimulated [3S]-GTPγS binding mediated by human muscarinic m1-m4 receptors: antagonist studies,”Br. J. Pharmacol., 1993, 109, 1120-1127.
Perez, V., et al., “Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment,”The Lancet,m May 31, 1997, 349, 1594-1597.
Tome, M.B., et al., “Serotonergic autoreceptor blocade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol,”J. Affect Disord, 1997, 44, 101-109.
Tome, M.B., et al., “Paroxetine and pindolol: a randomized trial of serotonergic antoreceptor blockade in the reduction of antidepressant latency,”Int. Clin. Pyschopharmacol, 1997, 12, 81-89.
Wilen, S.H., “Tables of Resolving Agents and Optical Resolutions,”Univ. of Notre Dame Press, Notre Dame, IN, E.L. Eliel (Ed.), 1972, p. 268-298.
WIlen, S.H., et al., “Strategies in optical resolutions,”Tetrahedron, 1977, 33, 2725-2736.
Gao Hong
Stack Gary Paul
Berch Mark L.
Habte Kahsay
Woodcock & Washburn LLP
Wyeth
LandOfFree
Antidepressant azaheterocyclymethyl derivatives of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antidepressant azaheterocyclymethyl derivatives of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antidepressant azaheterocyclymethyl derivatives of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3398832